Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
Case Report
[키워드] Affect
age
Antigen
autoantibodies
autoantibody
blunt
BNT162b2
C-reactive protein
children
children with MIS-C
Colchicine
computer tomography
Corona
coronavirus
COVID-19
COVID-19 mortality
COVID-19 vaccination
criteria
diagnosed
Diagnosis
disease
early stage
elevated
excluded
Factor
Fever
Frequency
functional
Hashimoto thyroiditis
higher risk
Hospitalized
IMPROVE
Inflammatory
initiated
intravenous
intravenous antibiotics
Intravenous immunoglobulin
MIS
MIS-C
mRNA
Multisystem inflammatory syndrome
occur
pathophysiology
pediatric
Pneumonia
positive
receptor
Release
risk
SARS-CoV infection
SARS-CoV-2 antibodies
SARS-COV-2 infection
SARS-CoV-2 vaccination
second vaccination
shown
syndrome
systemic inflammatory
the disease
the SARS-CoV-2
therapy
treated
troponin T
vaccination
Vaccine
Vaccine hesitancy
[DOI] 10.3390/vaccines9111353 PMC 바로가기 [Article Type] Case Report
[DOI] 10.3390/vaccines9111353 PMC 바로가기 [Article Type] Case Report